(Q34562294)

3 August 2017

1 reference

title

Immunology of hepatitis B infection (English)

1 reference

3 August 2017

1 reference

1 reference

Maria-Christina Jung

1

1 reference

PubMed ID

11892495

3 August 2017

Gerd R Pape

series ordinal

2

1 reference

3 August 2017

1 January 2002

1 reference

Lancet Infectious Diseases

3 August 2017

1 reference

3 August 2017

2

1 reference

3 August 2017

1

1 reference

3 August 2017

43-50

1 reference

Hepatitis B virus infection

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Natural killer T cell activation inhibits hepatitis B virus replication in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

The immune system. Second of two parts

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Naturally occurring variants of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Precore wild-type DNA and immune complexes persist in chronic hepatitis B after seroconversion: no association between genome conversion and seroconversion

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

The serology of chronic hepatitis B infection revisited

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Early and frequent detection of HBxAg and/or anti-HBx in hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Experimental WHV infection of woodchucks: an animal model of hepadnavirus-induced liver cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Woodchuck hepatitis virus infections: very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Relationship of virus dose to incubation time of clinical hepatitis and time of appearance of hepatitis???associated antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Effects of age and viral determinants on chronicity as an outcome of experimental woodchuck hepatitis virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Temporal pathogenesis of experimental neonatal woodchuck hepatitis virus infection: increased initial viral load and decreased severity of acute hepatitis during the development of chronic viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Hepatitis B virus immunopathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Characterization of age- and dose-related outcomes of duck hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Augmented hepatic interferon gamma expression and T-cell influx characterize acute hepatitis progressing to recovery and residual lifelong virus persistence in experimental adult woodchuck hepatitis virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Pathogenesis of experimental neonatal woodchuck hepatitis virus infection: chronicity as an outcome of infection is associated with a diminished acute hepatitis that is temporally deficient for the expression of interferon gamma and tumor necrosis f

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Induction of cytotoxic T lymphocytes with peptides in vitro: identification of candidate T-cell epitopes in hepatitis B virus X antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Low frequency of cytotoxic liver-infiltrating T lymphocytes specific for endogenous processed surface and core proteins in chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus. The CY1899 T Cell Vaccine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900172-4

7 January 2021

10.1016/S1473-3099(01)00172-4

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

11892495